Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells

Suk Ho Bhang, Seahyoung Lee, Tae Jin Lee, Wan Geun La, Hee Seok Yang, Seung-Woo Cho, Byung Soo Kim

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Despite the great potential of cell therapy for ischemic disease, poor cell survival after engraftment in ischemic tissue limits its efficacy. Here we tested a hypothesis that three-dimensionally grafted human umbilical vein endothelial cell (HUVEC) spheroids would exhibit improved angiogenic efficacy following transplantation into mouse ischemic limbs compared with HUVECs prepared by conventional two-dimensional monolayer culture. One day after surgical induction of hindlimb ischemia in athymic mice, HUVECs cultured in monolayer or HUVEC spheroids were transplanted intramuscularly into ischemic limbs. Four weeks after the treatment, in the spheroid HUVEC transplantation group, we observed increased hypoxia-inducible factor-1α expression, decreased apoptosis, and increased HUVEC survival in the ischemic tissue compared with the monolayer HUVEC transplantation group. Transplantation of HUVEC spheroids also resulted in enhanced and prolonged secretion of paracrine factors as well as enhanced expression of factors involved in the recruitment of circulating angiogenic progenitor cells. In summary, transplantation of HUVECs as spheroids enhanced cell survival, increased paracrine factor secretion, and showed a potential as a therapeutic method to treat ischemic tissue damages by promoting angiogenesis.

Original languageEnglish
Pages (from-to)310-319
Number of pages10
JournalTissue Engineering - Part A
Volume18
Issue number3-4
DOIs
Publication statusPublished - 2012 Feb 1

Fingerprint

Endothelial cells
Human Umbilical Vein Endothelial Cells
Monolayers
Cell Survival
Transplantation
Cell Transplantation
Tissue
Extremities
Cells
Hypoxia-Inducible Factor 1
Cell death
Hindlimb
Cell- and Tissue-Based Therapy
Nude Mice
Stem Cells
Ischemia
Apoptosis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering

Cite this

Bhang, Suk Ho ; Lee, Seahyoung ; Lee, Tae Jin ; La, Wan Geun ; Yang, Hee Seok ; Cho, Seung-Woo ; Kim, Byung Soo. / Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells. In: Tissue Engineering - Part A. 2012 ; Vol. 18, No. 3-4. pp. 310-319.
@article{49d5fad196cd43e3bdee110df9e64bcc,
title = "Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells",
abstract = "Despite the great potential of cell therapy for ischemic disease, poor cell survival after engraftment in ischemic tissue limits its efficacy. Here we tested a hypothesis that three-dimensionally grafted human umbilical vein endothelial cell (HUVEC) spheroids would exhibit improved angiogenic efficacy following transplantation into mouse ischemic limbs compared with HUVECs prepared by conventional two-dimensional monolayer culture. One day after surgical induction of hindlimb ischemia in athymic mice, HUVECs cultured in monolayer or HUVEC spheroids were transplanted intramuscularly into ischemic limbs. Four weeks after the treatment, in the spheroid HUVEC transplantation group, we observed increased hypoxia-inducible factor-1α expression, decreased apoptosis, and increased HUVEC survival in the ischemic tissue compared with the monolayer HUVEC transplantation group. Transplantation of HUVEC spheroids also resulted in enhanced and prolonged secretion of paracrine factors as well as enhanced expression of factors involved in the recruitment of circulating angiogenic progenitor cells. In summary, transplantation of HUVECs as spheroids enhanced cell survival, increased paracrine factor secretion, and showed a potential as a therapeutic method to treat ischemic tissue damages by promoting angiogenesis.",
author = "Bhang, {Suk Ho} and Seahyoung Lee and Lee, {Tae Jin} and La, {Wan Geun} and Yang, {Hee Seok} and Seung-Woo Cho and Kim, {Byung Soo}",
year = "2012",
month = "2",
day = "1",
doi = "10.1089/ten.tea.2011.0193",
language = "English",
volume = "18",
pages = "310--319",
journal = "Tissue Engineering - Part A.",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "3-4",

}

Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells. / Bhang, Suk Ho; Lee, Seahyoung; Lee, Tae Jin; La, Wan Geun; Yang, Hee Seok; Cho, Seung-Woo; Kim, Byung Soo.

In: Tissue Engineering - Part A, Vol. 18, No. 3-4, 01.02.2012, p. 310-319.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells

AU - Bhang, Suk Ho

AU - Lee, Seahyoung

AU - Lee, Tae Jin

AU - La, Wan Geun

AU - Yang, Hee Seok

AU - Cho, Seung-Woo

AU - Kim, Byung Soo

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Despite the great potential of cell therapy for ischemic disease, poor cell survival after engraftment in ischemic tissue limits its efficacy. Here we tested a hypothesis that three-dimensionally grafted human umbilical vein endothelial cell (HUVEC) spheroids would exhibit improved angiogenic efficacy following transplantation into mouse ischemic limbs compared with HUVECs prepared by conventional two-dimensional monolayer culture. One day after surgical induction of hindlimb ischemia in athymic mice, HUVECs cultured in monolayer or HUVEC spheroids were transplanted intramuscularly into ischemic limbs. Four weeks after the treatment, in the spheroid HUVEC transplantation group, we observed increased hypoxia-inducible factor-1α expression, decreased apoptosis, and increased HUVEC survival in the ischemic tissue compared with the monolayer HUVEC transplantation group. Transplantation of HUVEC spheroids also resulted in enhanced and prolonged secretion of paracrine factors as well as enhanced expression of factors involved in the recruitment of circulating angiogenic progenitor cells. In summary, transplantation of HUVECs as spheroids enhanced cell survival, increased paracrine factor secretion, and showed a potential as a therapeutic method to treat ischemic tissue damages by promoting angiogenesis.

AB - Despite the great potential of cell therapy for ischemic disease, poor cell survival after engraftment in ischemic tissue limits its efficacy. Here we tested a hypothesis that three-dimensionally grafted human umbilical vein endothelial cell (HUVEC) spheroids would exhibit improved angiogenic efficacy following transplantation into mouse ischemic limbs compared with HUVECs prepared by conventional two-dimensional monolayer culture. One day after surgical induction of hindlimb ischemia in athymic mice, HUVECs cultured in monolayer or HUVEC spheroids were transplanted intramuscularly into ischemic limbs. Four weeks after the treatment, in the spheroid HUVEC transplantation group, we observed increased hypoxia-inducible factor-1α expression, decreased apoptosis, and increased HUVEC survival in the ischemic tissue compared with the monolayer HUVEC transplantation group. Transplantation of HUVEC spheroids also resulted in enhanced and prolonged secretion of paracrine factors as well as enhanced expression of factors involved in the recruitment of circulating angiogenic progenitor cells. In summary, transplantation of HUVECs as spheroids enhanced cell survival, increased paracrine factor secretion, and showed a potential as a therapeutic method to treat ischemic tissue damages by promoting angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84856287996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856287996&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2011.0193

DO - 10.1089/ten.tea.2011.0193

M3 - Article

C2 - 21902465

AN - SCOPUS:84856287996

VL - 18

SP - 310

EP - 319

JO - Tissue Engineering - Part A.

JF - Tissue Engineering - Part A.

SN - 1937-3341

IS - 3-4

ER -